Early loss of pregnancy after intravitreal bevacizumab injection

Acta Ophthalmologica

Volumn 88, Issue 4, 2010, Pages

  Petrou, Petros ^a   Georgalas, Ilias ^a   Giavaras, Georgios ^b   Anastasiou, Eleni ^b   Ntana, Zoi ^b   Petrou, Constantinos ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CHORIONIC GONADOTROPIN BETA SUBUNIT; HEMOGLOBIN A1C; INSULIN;

ADULT; CASE REPORT; DIABETIC RETINOPATHY; FEMALE; GYNECOLOGICAL EXAMINATION; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; LETTER; MYOPIA; OPHTHALMOSCOPY; PANRETINAL PHOTOCOAGULATION; PREGNANCY; PRIORITY JOURNAL; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINA MACULA DEGENERATION; SIDE EFFECT; SPONTANEOUS ABORTION; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

ABORTION, SPONTANEOUS; ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; HUMANS; INJECTIONS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY; VITREOUS HEMORRHAGE;

EID: 77952790354     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01572.x     Document Type: Letter

References (5)

1. Avery RL, Pearlman J, Pieramici DJ et al. (2006 Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113 : 1695.
2. Csaky K 2007) Safety surveillance in the anti-VEGF era: myths and misconceptions. http://www.osnsupersite.com/view.aspx?rid=19510. [Accessed 10th April 2009].
3. Rodrigues EB, Shiroma H, Meyer CH, Maia M Farah ME (2007 Metrorrhagia after intravitreal injection of bevacizumab. Acta Ophthalmol Scand 85 : 915 916.
4. Rosen E, Rubowitz A Ferencz JR (2009 Exposure to verteporfin and bevacizumab therapy for choroidal neovascularization secondary to punctate inner choroidopathy during pregnancy. Eye 23 : 1479.
5. US Food and Drug Administration 2005) AVASTIN (bevacizumab). http://www.fda.gov/medwatch/SAFETY/2005/Jan-PI/Avastin-PI.pdf. [Accessed 10th April 2009].